Gj. Klapstein et Wf. Colmers, NEUROPEPTIDE-Y SUPPRESSES EPILEPTIFORM ACTIVITY IN RAT HIPPOCAMPUS IN-VITRO, Journal of neurophysiology, 78(3), 1997, pp. 1651-1661
Neuropeptide Y (NPY) potently inhibits glutamate-mediated synaptic tra
nsmission in areas CA1 and CA3 of the rat hippocampus without affectin
g other synaptic inputs onto principal cells of the hippocampal format
ion, suggesting that its biological role may include the regulation of
excitability within the hippocampus. Here we examine NPY's actions in
three in vitro models of epilepsy [0 Mg2+-, picrotoxin-, and stimulus
-train-induced bursting (STIB)] with the use of extracellular and whol
e cell patch-clamp recordings from rat hippocampal-entorhinal cortex s
lices. Perfusion of the slice with saline that had Mg2+ omitted (0 Mg2
+) or that had picrotoxin (100 mu M) added resulted in brief spontaneo
us bursts (SBs) resembling interictal discharges. SE frequency is sign
ificantly reduced in both models by 1 mu M NPY and by the Y-2-preferri
ng agonists peptide (P)YY3-36 (1 mu M) and 1-4-(6-aminohexanoic acid)-
25-36 ([ahx(5-24)] NPY; 3 mu M). The Y-1-preferring agonist Leu(31)-Pr
o(34)NPY (1 mu M) is considerably less potent, but also reduces burst
frequency, even in the presence of the selective Y-1 receptor antagoni
st GR231118, suggesting the involvement of a different receptor. In ST
IB, high frequency stimulus trains to stratum radiatum of area CA2/CA3
result in clonic or tonic-clonic ictaform primary afterdischarges (1
degrees ADs) as well as longer, spontaneous secondary ictaform dischar
ges and SBs similar to those in the other models. 1 degrees AD duratio
n is greatly reduced or abolished by Y-2-but not Y-1-preferring agonis
ts. SBs, although variable, were inhibited by both Y-1 and Y-2 agonist
s. In single and dual whole cell recordings from CA3 pyramidal cells,
we frequently observed spontaneous, rhythmic synchronous events (SRSEs
) arising after several STIB stimuli. Once established, SRSEs persist
in the absence of further stimuli and are insensitive to the applicati
on of NPY. SRSEs in pyramidal cells typically occur at 2-4 Hz, are out
ward currents when cells are clamped near rest (>100 pA at a holding p
otential of -55 mV), reverse between -60 and -70 mV, and are inhibited
by 100 mu M picrotoxin. indicating involvement of gamma-aminobutyric
acid-A receptors. They are inhibited by blockers of lpha-amino-3-hydro
xy-5-methyl-4-isoxazolepropionic acid (AMPA) but not N-methyl-D-aspart
ate receptors. Whole cell patch-clamp recordings from interneurons in
CA3 after STIB reveal NPY-insensitive, rhythmic, inward AMPA-receptor-
mediated currents that are similar in frequency to SRSEs seen in pyram
idal cells. We conclude that NPY, acting predominantly via Y-2 recepto
rs, can dramatically inhibit epileptiform activity in three fundamenta
lly different in vitro models of epilepsy without affecting endogenous
inhibitory activity. The results also provide support for the hypothe
sis that endogenous NPY may normally control excitability in the hippo
campus and suggest the potential for NPY receptors as targets for anti
convulsant therapy.